Latest insights on IO treatment of resectable NSCLC
Luis Paz-Ares and Federico Cappuzzo share their insights on optimal timing for IO treatment in resectable NSCLC and reflect on key data presented at WCLC and ESMO 2024.
The latest evidence supporting the use of IO in resectable NSCLC
Key treatment considerations: PD-L1 expression status and disease Stage
Optimizing IO treatment approaches
Assessing the risk of delaying surgery
Unanswered questions and future treatments for resectable NSCLC
Final thoughts



